• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Sunscreen reduces melanoma risk by 40 per cent in young people

Bioengineer by Bioengineer
July 18, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely used sunscreen.

Melanoma is the most common cancer diagnosed in Australian men aged 25-49 years and second most common cancer in women aged 25-49 years, after breast cancer. Approximately two in three Australians will be diagnosed with melanoma or other types of skin cancer by the time they are 70 years old.

Published today in JAMA Dermatology, this is the first study to examine the association between sunscreen use with melanoma risk in young people under 40 years. The study analysed data collected from nearly 1700 people who participated in the Australian Melanoma Family Study.

"Our study shows that sunscreen use in childhood and adulthood was protective against melanoma in young people 18-40 years old, with their risk reduced by 35 to 40 percent for regular sunscreen users compared to people who rarely used it," said lead researcher Associate Professor Anne Cust, who heads the Cancer Epidemiology and Prevention Research group at the University of Sydney's School of Public Health and Melanoma Institute Australia.

"The association of sun exposure and sunburn with melanoma risk, particularly in childhood, is well established and this study showed that regularly using sunscreen was protective against the harmful effects of sun exposure.

"Regular users of sunscreen were more likely to be female, younger, of British or northern European ancestry, and have higher education levels, lighter skin pigmentation, and a strong history of blistering sunburn.

"People were less likely to use sunscreen if they were male, older, less educated, or had skin that was darker or more resistant to sunburn.

"Despite sunscreen being widely available and recommended for sun protection, optimising the use of sunscreens remains a challenge and controversies continue to surround its use.

"This study confirms that sunscreen is an effective form of sun protection and reduces the risk of developing melanoma as a young adult. Sunscreen should be applied regularly during childhood and throughout adulthood whenever the UV Index is 3 or above, to reduce risk of developing melanoma and other skin cancers.

"Some population subgroups such as people with sun-sensitive skin or with many moles might get a stronger benefit from using sunscreen," she said.

###

The Australian Melanoma Family Study was conducted in collaboration with Cancer Council Queensland and University of Melbourne and funded by the National Health and Medical Research Council (NHMRC), Cancer Council NSW, Cancer Council Victoria, Cancer Council Queensland, and the US National Institutes of Health.

Media Contact

Kobi Print
[email protected]
61-481-012-729
@SydneyUni_Media

http://www.usyd.edu.au/

http://dx.doi.org/10.1001/jamadermatol.2018.1774

Share13Tweet7Share2ShareShareShare1

Related Posts

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

February 7, 2026

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

February 7, 2026

Barriers and Boosters of Seniors’ Physical Activity in Karachi

February 7, 2026

Evaluating Pediatric Emergency Care Quality in Ethiopia

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

Barriers and Boosters of Seniors’ Physical Activity in Karachi

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.